Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: three case reports and review of literature

K Mathur, S Morris, C Deighan, R Green… - Journal of Clinical …, 2008 - Wiley Online Library
Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis (NFD/NSF) is a recently
recognized systemic fibrosing disorder that develops in the context of renal insufficiency. Its …

Extracorporeal photopheresis affects co-stimulatory molecule expression and interleukin-10 production by dendritic cells in graft-versus-host disease patients

M Di Renzo, P Sbano, G De Aloe… - Clinical & …, 2008 - academic.oup.com
Graft-versus-host disease (GVHD) is a major complication of allogeneic bone marrow
transplantation. Extracorporeal photochemotherapy (ECP) has been introduced as an …

Multicenter photopheresis intervention trial in early-stage mycosis fungoides

R Talpur, MF Demierre, L Geskin, E Baron… - … Myeloma and Leukemia, 2011 - Elsevier
Purpose To demonstrate the efficacy of the UVAR XTS Photopheresis System and evaluate
health-related quality of life in patients with early-stage mycosis fungoides (MF). Patients …

Extra corporeal photochemotherapy in steroid refractory graft versus host disease: a review of guidelines and recommendations

S Mohammadi, AM Mohammadi… - … and Apheresis Science, 2017 - Elsevier
Regardless of remarkable progresses in prevention and treatment approaches, graft versus
host disease (GVHD) remains a major impediment for successful allogeneic hematopoietic …

Modulation and apoptosis of neutrophil granulocytes by extracorporeal photopheresis in the treatment of chronic graft-versus-host disease

C Franklin, E Cesko, U Hillen, B Schilling, S Brandau - PLoS One, 2015 - journals.plos.org
Chronic graft-versus-host disease (cGVHD) is a common side effect of allogeneic stem cell
transplantation and a major cause of morbidity and mortality in affected patients. Especially …

The value of extracorporeal photopheresis as an immunosuppression-modifying approach in solid organ transplantation: a potential solution to an unmet medical …

JF Augusto, C Benden, F Diekmann… - Frontiers in …, 2024 - frontiersin.org
Allograft rejection is a critical issue following solid organ transplantation (SOT).
Immunosuppressive therapies are crucial in reducing risk of rejection yet are accompanied …

Sclerodermatous graft‐versus‐host disease: clinical spectrum and therapeutic challenges

JML White, D Creamer, AWP Du Vivier… - British Journal of …, 2007 - academic.oup.com
Sclerodermatous graft‐versus‐host disease (GVHD) is a rare complication of bone marrow
transplantation. While GVHD is often associated with the beneficial graft vs. tumour effect, it …

Extracorporeal photopheresis: what is it and when should it be used?

J Scarisbrick - Clinical and experimental dermatology, 2009 - academic.oup.com
Extracorporeal photopheresis (ECP) is a technique that was developed> 20 years ago to
treat erythrodermic cutaneous T‐cell lymphoma (CTCL). The technique involves removal of …

Extracorporeal photopheresis (ECP) in patients with steroid-dependent Crohn's disease: an open-label, multicenter, prospective trial

W Reinisch, R Knobler, PJ Rutgeerts… - Inflammatory bowel …, 2013 - academic.oup.com
Background Extracorporeal photopheresis (ECP) involves ex vivo leukocyte treatment with
methoxsalen and UVA light to generate a tolerogenic response. A previous trial …

Extracorporeal Photopheresis in Dermatological Diseases

H Terhaar, M Saleem, N Yusuf - International Journal of Molecular …, 2024 - mdpi.com
Extracorporeal photopheresis (ECP) is an apheresis procedure that is conventionally used
as a first-line treatment for cutaneous and leukemic subtypes of T-cell lymphoma, such as …